Global investment firm KKR has signed definitive agreements to acquire 100% of Medicover India, the hospital operations of Stockholm-listed healthcare and diagnostic provider MedicoverAB, at an enterprise value of €1.2 billion (approximately $1.4 billion).
Under the terms of the agreement, KKR-managed funds will acquire both the 66.1% stake held by Medicover AB and the remaining 33.9% stake held by minority shareholders. The divestment will yield gross cash proceeds of approximately €740 million ($855 million) for Medicover AB, allowing the Swedish firm to focus strategically and operationally on its core European markets, including Poland, Germany, and Romania.
Established in 2017, Medicover India operates a multi-specialty hospital network of 24 hospitals with approximately 4,800 beds across southern and western India. Supported by more than 1,900 doctors spanning over 80 clinical specialties, the network serves millions of patients annually and generated €220.5 million in revenue over the 12 months ending June 30, 2026.
“This transaction represents an important milestone in supporting the long-term growth of India’s healthcare infrastructure,” said Akshay Tanna, Partner and Head of India Private Equity at KKR. KKR plans to support Medicover India’s clinicians and staff to expand patient access to high-quality care and advanced clinical solutions.
The transaction is subject to regulatory and merger-control approvals and is expected to close in the fourth quarter of 2026.
Written by: Pragna Biswas
Graphics by: Pramit Hazra
